Trial intelligence / Profile preview

Dendrobium officinale granules for oral mucositis caused by tumor treatment

ChiCTR2300069861Phase 2Not yet recruiting

Sponsor
Shanghai Hospital of Integrated Traditional Chinese and Western Medicine
Start
Jul 2022
Countries
1
01

Overview

Phase 2, randomised trial of dendrobium officinale in stomatitis and cancer (2 arms), sponsored by Shanghai Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoints: Mean ulcer stage, Pain score and 1 more. Planned start Jul 2022; status: not yet recruiting.

02

Drugs

dendrobium officinale
03

Conditions

stomatitiscancer

Beyond the preview

Go deeper on ChiCTR2300069861.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300069861.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call